Fertility Clinic Business Valuation

Fertility Clinic & IVF Practice Valuation Calculator & Exit Planning Built for REI Practice Owners

Your Fertility Clinic Valuation: What Buyers Pay for High-Margin Reproductive Medicine

★★★★★1,000+ Business Owners Have Joined YourExitValue.com

Free Fertility Clinic Valuation Calculator

See what your business is worth in 60 seconds

Your total sales before any expenses
Salary + distributions + owner perks (SDE)
FreeNo email requiredInstant results
Current Multiples (2026)

What Fertility Clinic Businesses Actually Sell For

High-performing fertility clinics trade between 5.0x–10.0x SDE (Seller's Discretionary Earnings) for owner-dependent practices, and 10.0x–20.0x EBITDA for larger, multi-physician clinics with strong lab quality, diversified revenue streams, and institutional payer relationships.

Method
Typical Range
Premium for Well-Run Businesses
SDE Multiple
Most common for owner-operated businesses
5.0x – 10.0x
30-50% Higher
Revenue Multiple
Used by strategic buyers
1.5x – 3.5x
30-50% Higher
EBITDA Multiple
For larger businesses $2M+ EBITDA
10.0x – 20.0x
30-50% Higher
The Problem

What's My Fertility Clinic Business Worth?

Building a successful fertility practice requires years of clinical expertise, regulatory compliance, patient trust, and operational precision. But converting that reputation and revenue into a clear, defensible valuation is where most clinic owners struggle. You understand your patient volume and procedure mix, yet buyers evaluate fertility businesses through entirely different lenses—cycle volume growth, SART success rates, physician independence, and payer relationships. Without knowing your real valuation, you risk leaving substantial exit value on the table or pursuing buyers who don't value your specific strengths.

Start Tracking My Value →
75%

of businesses listed for sale never close — mostly due to preventable, fixable issues

20-40%

more sale price for owners who started exit planning 3+ years before going to market

3–5 yrs

optimal lead time to identify gaps, fix value drivers, and maximize your exit price

6 Key Value Drivers

What Actually Drives Fertility Clinic Value

Six key drivers determine whether buyers see your fertility clinic as a high-margin acquisition or a mature practice with consolidation risk. Here's what the market values most:

Driver 1
Cycle Volume
Growing IVF Cycle Count
Buyers prioritize clinics showing 10%+ annual cycle growth, signaling strong market demand and expansion potential within the platform. Flat or declining volume signals market saturation to consolidators and limits acquisition appetite and earnout likelihood. Track IVF, FET, egg freezing, and donor cycles separately on monthly dashboards with conversion metrics. Show year-over-year growth patterns and pipeline metrics (consultations, referral sources, conversion rates by referral channel). Clinics with diverse cycle types (IVF, donor IVF, freeze-only, surrogacy coordination) demonstrate operational resilience and market reach.
Declining cycles = buyer concern
Driver 2
Success Rates
Strong SART-Reported Outcomes
SART-reported pregnancy and live birth rates provide the objective clinical quality evidence that sophisticated fertility clinic acquirers evaluate before any other operational metric during preliminary screening. Clinics with success rates consistently above national averages across all age groups and treatment types demonstrate the clinical excellence that attracts patients, supports premium pricing, and justifies higher acquisition multiples. Document your outcomes by patient age bracket, treatment protocol type, and fresh versus frozen transfer cycles to provide the granular clinical data that buyers and their medical advisors require during comprehensive due diligence evaluation.
Poor outcomes = competitive disadvantage
Driver 3
Physician Coverage
Multiple REIs, Not Owner-Dependent
Physician coverage with multiple reproductive endocrinologists and infertility specialists on staff who are not dependent on the selling owner dramatically reduces acquisition transition risk and supports the patient volume capacity required for practice growth. Buyers evaluate the number of practicing REIs, their individual cycle volumes and clinical outcomes, employment or partnership agreement terms including non-compete provisions, and the realistic likelihood of physician retention through an ownership change. Practices with three or more REIs under long-term agreements with restrictive non-compete covenants command the highest premiums from private equity buyers.
Solo REI = key person risk
Driver 4
Lab Quality
Accredited Lab, Strong Embryology Team
An accredited lab with experienced embryology leadership is non-negotiable for buyer confidence and premium acquisition valuation multiples and pricing power. CLIA certification, CAP accreditation, and documented embryology expertise reassure buyers about quality consistency, reduce regulatory compliance risk substantially, and minimize operational disruption after acquisition. Invest in lab director retention, embryologist training programs, equipment modernization, quality metrics tracking, and competency assessments. Strong lab quality reduces malpractice risk, directly supports higher success rates, improves operational efficiency, reduces cycle times, and justifies 15–20% valuation premiums.
Weak lab = outcomes risk
Driver 5
Ancillary Services
Egg Freezing, Donor, Surrogacy Coordination
Ancillary fertility services including egg freezing for fertility preservation, donor egg and donor sperm programs, gestational surrogacy coordination services, and preimplantation genetic testing generate additional revenue streams while increasing patient lifetime value significantly beyond standard IVF cycle revenue alone. These services demonstrate clinical sophistication and expand the addressable patient population beyond couples experiencing infertility to include single individuals, same-sex couples, and patients seeking elective fertility preservation. Document revenue from each ancillary service line and growth trends to quantify this expanding revenue opportunity for buyers.
IVF-only = limited capture
Driver 6
Payer & Employer Relationships
Progyny/Carrot, Employer Benefits
Relationships with fertility benefit management companies like Progyny and Carrot Fertility, combined with direct employer benefit program participation, create structured patient referral channels that generate consistent cycle volume with commercially insured patients who typically represent the highest per-cycle reimbursement rates. These payer relationships effectively function as contracted referral pipelines that reduce patient acquisition costs while ensuring favorable payer mix composition. Document all benefit management company contracts, employer relationships, the percentage of total cycles sourced through these channels, and contract renewal terms.
Declining cycles = buyer concern
Success Story

Results from Real Owners

See how business owners used YourExitValue to maximize their exit price.

"
"Good fertility practice but too dependent on me and no employer benefit contracts. YourExitValue showed me to add a physician and pursue Progyny. Hired an REI, joined benefit networks, and attracted a major fertility platform. Sold for $3.5M more than expected."
Dr. Jennifer Park, MDPacific Fertility Center, San Diego, CA
MetricBeforeAfter
VALUATION$6.5M$10.0M
ANNUAL IVF CYCLES280420
Total Value Added
+$3.5M
by focusing on the right value drivers
How We Value Your Business

How to Value a Fertility Clinic

Calculating your fertility clinic valuation starts with understanding the two main approaches buyers use: Seller's Discretionary Earnings (SDE) and EBITDA. For owner-dependent clinics, SDE captures the true cash flow available to an owner or buyer by starting with net profit and adding back owner physician salary (adjusted to market-rate for an employed REI), practice expenses, CME, malpractice insurance above baseline costs, and one-time capital expenditures. EBITDA applies to larger, multi-physician operations where earnings are calculated before interest, taxes, depreciation, and amortization, providing a clearer picture of operational economics and buyer return potential. SDE works best for single-physician practices, while EBITDA is standard for multi-physician clinics with hired management and institutional structure. Here's the step-by-step valuation process used by consolidators, DSOs, and institutional buyers evaluating acquisitions. First, gather your last 2–3 years of tax returns, detailed P&L statements broken by service line (IVF, FET, egg freezing, donor, surrogacy), and practice management reports showing patient volume by cycle type, success metrics by age cohort, payer mix (insurance, self-pay, employer benefits, institutional), and customer acquisition costs by channel. Buyers request these during due diligence, so organized documentation accelerates the entire process and builds confidence with acquisition teams evaluating your practice. Include monthly cycle volume data to show growth trajectory, seasonality patterns, and revenue consistency through economic cycles. Next, calculate your SDE by starting with net profit and adding back: your owner physician salary (compare to employed REI market rates—typically $300K–$450K depending on geography, subspecialty, and experience level), practice-paid malpractice insurance above baseline coverage, CME and conferences, licensing and regulatory fees, compliance training, and any one-time capital expenditures or facility improvements. Document these add-backs carefully with supporting records; buyers scrutinize SDE add-backs closely and verify them through detailed CPA review and audit procedures. Once you have your SDE, apply a multiple based on your clinic's strength across the six valuation drivers mentioned earlier. Benchmark multiples range from 5.0x–7.0x SDE for owner-dependent practices with solid outcomes but flat growth trajectory, to 8.0x–10.0x+ SDE for multi-physician clinics with 15%+ annual cycle growth and strong institutional payer relationships. For EBITDA-based valuations, clinics with $1M+ EBITDA trade at 10.0x–20.0x depending on cycle growth rate, revenue diversification, scale, buyer type (DSO, private equity, regional health system), and competitive market dynamics. Different buyer types value multiples differently: independent aggregators often pay 6.0x–8.0x, DSOs 7.0x–12.0x, and PE firms 9.0x–15.0x when growth and margins align. For example, if your clinic generates $500K SDE with flat cycle growth, one physician, and limited ancillary services, expect 5.5x–6.5x multiples, yielding $2.75M–$3.25M valuation. If you operate a multi-physician clinic with $750K EBITDA, 15% annual cycle growth, 50%+ live birth rates, diversified revenue streams (egg freezing, donor programs, surrogacy coordination), and 35% patient volume through institutional payers like Progyny, expect 9.0x–11.0x multiples, reaching $6.75M–$8.25M. Most quality fertility clinic transactions in this market close in the 6.0x–10.0x range depending on growth trajectory and operational maturity profile level. The six valuation drivers (cycle growth, success rates, physician independence, lab quality, ancillary services, and payer relationships) directly influence which multiple buyers apply to your practice. A clinic with flat cycles, single-physician dependency, and core IVF-only services might trade at 4.5x; one excelling across all drivers could reach 12.0x or higher premium multiples. Track these drivers monthly on dashboards and prioritize improving the weakest area first—strengthening any single driver often yields 10–20% valuation uplift in buyer offers. Use our valuation calculator for personalized cycle-based analysis, and review comparable fertility clinic transactions in your region to benchmark against peer practices and market rates. For strategic questions about transaction structure, earnout negotiations, seller financing options, tax planning, or specific guidance about other medical practices or dermatology practice acquisitions, our team is available to discuss your specific situation and connect you with experienced healthcare M&A advisors, investment bankers, and transaction specialists.

Facility quality and geographic positioning also influence fertility clinic valuations. Modern clinical facilities with dedicated procedure rooms, on-site embryology laboratories meeting regulatory standards, and comfortable patient environments demonstrate the infrastructure investment that supports premium multiples. Clinics located in metropolitan areas with large populations of women aged 30 to 44 — the primary fertility treatment demographic — benefit from stronger patient demand and attract more buyer interest than clinics in smaller markets with limited demographic support for sustained cycle volume growth. Related industries that follow similar consolidation dynamics include Ambulatory Surgery Center (ASC) and Dental Practice.

Start Tracking Your Value →
FAQ

Common Questions About Fertility Clinic Business Valuation

What multiple do fertility clinics sell for?
Fertility clinics sell for 5.0x to 10.0x SDE or 10.0x to 20.0x EBITDA depending on cycle volume, live birth success rates, physician depth, and payer diversification. Multi-REI practices performing 500+ annual cycles with above-median SART success rates and diversified payer contracts receive 8.0x-10.0x SDE. Single-physician clinics with under 200 annual cycles typically receive 5.0x-6.5x SDE due to key-person dependency risk. EBITDA multiples of 15.0x-20.0x apply to platform-scale practices with institutional payer contracts through Progyny, Carrot, or employer benefit networks, where hospital systems and PE-backed fertility platforms aggressively compete for acquisitions driving premium valuations.
How important are success rates for fertility value?
High-performing fertility clinics trade at 5.0x–10.0x SDE or 10.0x–20.0x EBITDA. Single-physician clinics with solid outcomes but flat growth sit at 5.0x–7.0x; multi-physician clinics with 15%+ cycle growth, strong success rates, and diversified payer relationships reach 8.0x–12.0x+. DSO consolidators, private equity groups, and regional health systems all bid aggressively for clinics with proven cycle volume, outcomes, and institutional relationships.
Who buys fertility clinics?
PE-backed women's health platforms like Kindbody and Prelude Fertility pay 12x-20x EBITDA for multi-REI fertility clinics with strong cycle volume and diversified payer mix. Hospital systems and academic medical centers pay 10x-15x EBITDA integrating fertility services into existing women's health programs. Regional fertility practice groups pay 8x-12x EBITDA expanding geographic coverage and specialty capabilities. Independent REIs acquiring additional locations pay 5x-8x SDE building multi-clinic platforms. Fertility benefits network administrators including Progyny and Carrot increasingly acquire or partner with high-performing clinics to ensure network quality and capacity.
Does having multiple REIs affect value?
Multiple REIs significantly increase fertility clinic valuations by 30-50% because multi-physician practices reduce key-person dependency and increase patient capacity. Single-REI clinics trade at 5.0x-7.0x SDE because buyers face immediate revenue risk if the physician departs post-acquisition. Practices with 2-3+ REIs command 8.0x-10.0x SDE since patient relationships distribute across the practice rather than concentrating with one provider. Multiple physicians also enable subspecialty differentiation — one REI focusing on complex IVF while another handles IUI and egg freezing — broadening the patient base. Add associate REIs 12-18 months before selling to demonstrate the practice supports multiple physicians.
How important are fertility benefit networks?
Fertility benefit network participation is increasingly important because employer-sponsored fertility coverage through Progyny, Carrot, Maven, and WINFertility now represents 25-40% of IVF cycle volume at top clinics. Network participation drives patient volume through preferred provider referrals and streamlines reimbursement at contracted rates averaging $15,000-25,000 per IVF cycle. Clinics participating in 3+ major benefit networks command 10x-14x EBITDA versus 7x-10x for non-networked practices dependent on out-of-pocket patients. Buyers value network relationships because they create predictable patient pipelines with pre-authorized coverage and lower marketing cost per acquisition. Building network contracts requires SART reporting transparency and competitive success rates, making clinical outcomes the foundation of network eligibility.
What's the fastest way to increase my fertility clinic value?
Institutional payers (Progyny, Carrot, employer benefits plans) drive highly predictable patient volume and dramatically reduce customer acquisition costs and marketing spend. Clinics with 40%+ volume through institutional channels attract DSO buyers and institutional investment groups. Document contracted rates, payment terms, patient volume by payer, and retention rates. Payer diversification often justifies 15–25% valuation premiums versus single-payer dependent clinics.

Know Your Value. Exit on Your Terms.

Join 1,000+ business owners who track their value monthly and plan their exit with confidence.

$99/month · Cancel anytime · No contracts

The only platform combining business valuation, exit planning, and personal financial planning for small business owners. Track your value monthly. Exit on your terms.

Platform

Sample Industries

Resources

© 2026 YourExitValue.com · hello@yourexitvalue.com
Fertility Clinic Business Valuation

Fertility Clinic & IVF Practice Valuation Calculator & Exit Planning Built for REI Practice Owners

Your Fertility Clinic Valuation: What Buyers Pay for High-Margin Reproductive Medicine

★★★★★1,000+ Business Owners Have Joined YourExitValue.com

Free Fertility Clinic Valuation Calculator

See what your business is worth in 60 seconds

Your total sales before any expenses
Salary + distributions + owner perks (SDE)
FreeNo email requiredInstant results
Current Multiples (2026)

What Fertility Clinic Businesses Actually Sell For

High-performing fertility clinics trade between 5.0x–10.0x SDE (Seller's Discretionary Earnings) for owner-dependent practices, and 10.0x–20.0x EBITDA for larger, multi-physician clinics with strong lab quality, diversified revenue streams, and institutional payer relationships.

Method
Typical Range
Premium for Well-Run Businesses
SDE Multiple
Most common for owner-operated businesses
5.0x – 10.0x
30-50% Higher
Revenue Multiple
Used by strategic buyers
1.5x – 3.5x
30-50% Higher
EBITDA Multiple
For larger businesses $2M+ EBITDA
10.0x – 20.0x
30-50% Higher
The Problem

What's My Fertility Clinic Business Worth?

Building a successful fertility practice requires years of clinical expertise, regulatory compliance, patient trust, and operational precision. But converting that reputation and revenue into a clear, defensible valuation is where most clinic owners struggle. You understand your patient volume and procedure mix, yet buyers evaluate fertility businesses through entirely different lenses—cycle volume growth, SART success rates, physician independence, and payer relationships. Without knowing your real valuation, you risk leaving substantial exit value on the table or pursuing buyers who don't value your specific strengths.

Start Tracking My Value →
75%

of businesses listed for sale never close — mostly due to preventable, fixable issues

20-40%

more sale price for owners who started exit planning 3+ years before going to market

3–5 yrs

optimal lead time to identify gaps, fix value drivers, and maximize your exit price

6 Key Value Drivers

What Actually Drives Fertility Clinic Value

Six key drivers determine whether buyers see your fertility clinic as a high-margin acquisition or a mature practice with consolidation risk. Here's what the market values most:

Driver 1
Cycle Volume
Growing IVF Cycle Count
Declining cycles = buyer concern
Driver 2
Success Rates
Strong SART-Reported Outcomes
Poor outcomes = competitive disadvantage
Driver 3
Physician Coverage
Multiple REIs, Not Owner-Dependent
Solo REI = key person risk
Driver 4
Lab Quality
Accredited Lab, Strong Embryology Team
Weak lab = outcomes risk
Driver 5
Ancillary Services
Egg Freezing, Donor, Surrogacy Coordination
IVF-only = limited capture
Driver 6
Payer & Employer Relationships
Progyny/Carrot, Employer Benefits
No benefit networks = access limits
Success Story

Results from Real Owners

See how business owners used YourExitValue to maximize their exit price.

"
"Good fertility practice but too dependent on me and no employer benefit contracts. YourExitValue showed me to add a physician and pursue Progyny. Hired an REI, joined benefit networks, and attracted a major fertility platform. Sold for $3.5M more than expected."
Dr. Jennifer Park, MDPacific Fertility Center, San Diego, CA
MetricBeforeAfter
VALUATION$6.5M$10.0M
ANNUAL IVF CYCLES280420
Total Value Added
+$3.5M
by focusing on the right value drivers
How We Value Your Business

How to Value a Fertility Clinic

Start Tracking Your Value →
FAQ

Common Questions About Fertility Clinic Business Valuation

What multiple do fertility clinics sell for?
Fertility clinics sell for 5.0x to 10.0x SDE or 10.0x to 20.0x EBITDA depending on cycle volume, live birth success rates, physician depth, and payer diversification. Multi-REI practices performing 500+ annual cycles with above-median SART success rates and diversified payer contracts receive 8.0x-10.0x SDE. Single-physician clinics with under 200 annual cycles typically receive 5.0x-6.5x SDE due to key-person dependency risk. EBITDA multiples of 15.0x-20.0x apply to platform-scale practices with institutional payer contracts through Progyny, Carrot, or employer benefit networks, where hospital systems and PE-backed fertility platforms aggressively compete for acquisitions driving premium valuations.
How important are success rates for fertility value?
High-performing fertility clinics trade at 5.0x–10.0x SDE or 10.0x–20.0x EBITDA. Single-physician clinics with solid outcomes but flat growth sit at 5.0x–7.0x; multi-physician clinics with 15%+ cycle growth, strong success rates, and diversified payer relationships reach 8.0x–12.0x+. DSO consolidators, private equity groups, and regional health systems all bid aggressively for clinics with proven cycle volume, outcomes, and institutional relationships.
Who buys fertility clinics?
PE-backed women's health platforms like Kindbody and Prelude Fertility pay 12x-20x EBITDA for multi-REI fertility clinics with strong cycle volume and diversified payer mix. Hospital systems and academic medical centers pay 10x-15x EBITDA integrating fertility services into existing women's health programs. Regional fertility practice groups pay 8x-12x EBITDA expanding geographic coverage and specialty capabilities. Independent REIs acquiring additional locations pay 5x-8x SDE building multi-clinic platforms. Fertility benefits network administrators including Progyny and Carrot increasingly acquire or partner with high-performing clinics to ensure network quality and capacity.
Does having multiple REIs affect value?
Multiple REIs significantly increase fertility clinic valuations by 30-50% because multi-physician practices reduce key-person dependency and increase patient capacity. Single-REI clinics trade at 5.0x-7.0x SDE because buyers face immediate revenue risk if the physician departs post-acquisition. Practices with 2-3+ REIs command 8.0x-10.0x SDE since patient relationships distribute across the practice rather than concentrating with one provider. Multiple physicians also enable subspecialty differentiation — one REI focusing on complex IVF while another handles IUI and egg freezing — broadening the patient base. Add associate REIs 12-18 months before selling to demonstrate the practice supports multiple physicians.
How important are fertility benefit networks?
Fertility benefit network participation is increasingly important because employer-sponsored fertility coverage through Progyny, Carrot, Maven, and WINFertility now represents 25-40% of IVF cycle volume at top clinics. Network participation drives patient volume through preferred provider referrals and streamlines reimbursement at contracted rates averaging $15,000-25,000 per IVF cycle. Clinics participating in 3+ major benefit networks command 10x-14x EBITDA versus 7x-10x for non-networked practices dependent on out-of-pocket patients. Buyers value network relationships because they create predictable patient pipelines with pre-authorized coverage and lower marketing cost per acquisition. Building network contracts requires SART reporting transparency and competitive success rates, making clinical outcomes the foundation of network eligibility.
What's the fastest way to increase my fertility clinic value?
Institutional payers (Progyny, Carrot, employer benefits plans) drive highly predictable patient volume and dramatically reduce customer acquisition costs and marketing spend. Clinics with 40%+ volume through institutional channels attract DSO buyers and institutional investment groups. Document contracted rates, payment terms, patient volume by payer, and retention rates. Payer diversification often justifies 15–25% valuation premiums versus single-payer dependent clinics.

Know Your Value. Exit on Your Terms.

Join 1,000+ business owners who track their value monthly and plan their exit with confidence.

$99/month · Cancel anytime · No contracts

The only platform combining business valuation, exit planning, and personal financial planning for small business owners. Track your value monthly. Exit on your terms.

Platform

Sample Industries

Resources

© 2026 YourExitValue.com · hello@yourexitvalue.com